1. D10 Pharmacodynamic Biomarkers For Selisistat: The Paddington Project. (17th September 2014) Authors: Pollio, G; Massai, L; Diamanti, D; Magnoni, L; Westerberg, G; Farmer, RE; Frost, C; Tabrizi, SJ; Landwehrmeyer, GB; Thomas, R Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 85(2014)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. F02 Selisistat: soluble HTT protein levels as a potential pharmacodynamic readout. (29th August 2012) Authors: Westerberg, G; Massai, L; Magnoni, L; Pollio, G; Tripepi, G; Diodato, E; Caricasole, A; Bernocco, S; Tabrizi, SJ; Landwehrmeyer, B Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. F04 Selisistat: potential pharmacodynamic readouts based on transcriptomics. (29th August 2012) Authors: Westerberg, G; Diamanti, D; Pollio, G; Mori, E; Fondelli, C; Morena, E; Magnoni, L; Tarditi, A; Malusa, F; Tabrizi, SJ; Landwehrmeyer, B; Caricasole, A Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗